• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

EMA - Articles and news items

FDA accepts Mylan and Biocon’s biosimilar biologics license application

Industry news / 12 January 2017 / Niamh Marriott, Digital Editor

This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers…

Janssen Pharmaceuticals Logo

New Marketing Authorisation Application submitted to EMA for Ibrutinib for the treatment of two forms of blood cancer

Industry news / 30 October 2013 / Johnson & Johnson

“The EMA Marketing Authorisation Application is an important milestone in the development of ibrutinib…”

Novartis logo

Alcon gains exclusive ex-US rights for ocriplasmin

Industry news, News / 16 March 2012 / Novartis

Potential first pharmacological treatment for symptomatic vitreomacular adhesion…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +